CiiTA Managing Partner Jason Hardaway to Speak at 15th Annual Medicaid and GP Congress

PORTLAND, Ore. – April 25, 2016 — CiiTA founder and managing partner Jason Hardaway is invited to speak at the upcoming 15th Annual Medicaid and GP Congress in Orlando, Florida May 18-20, 2016. This event, hosted by CBI, is an invaluable opportunity to learn and receive updates on government pharmaceutical programs while also having the opportunity to network with industry experts and leading consulting and legal firms.

Mr. Hardaway’s presentation at the CBI conference will be on May 20^th within the Finance Track and will address duplicate discounts between 340B and Medicaid, including why and how they occur, compliance, and the implications of state policies on duplicate discount risk.

For more information on the May 18-20 CBI conference, click here. (https://www.cbinet.com/conference/pc16149)

Jason Hardaway is a recognized expert on the federal 340B Program and a frequent presenter or panel member at 340B industry events.

CiiTA, LLC provides unique expertise and actionable market intelligence to pharmaceutical and biotechnology manufacturers participating in the 340B Drug Discount Program. We apply in-depth knowledge of 340B Program regulations and custom research to help manufacturers maintain strict compliance with Program guidelines while mitigating the financial risk of Program abuse.